Why the study?
Do SGLT2 inhibitors reduce left ventricular mass as assessed by cMRI?
Do SGLT2 inhibitors reduce left ventricular mass as assessed by cMRI?
SGLT2 inhibitors are associated with a reduction in left ventricular mass on cardiac MRI, providing imaging-based evidence for their role in favorable cardiac remodeling.
Answers are grounded in this paper and cite their sources.
Supports SGLT2 inhibitor use for reverse remodeling; confirms LV mass reduction on cMRI.
Sodium-glucose cotransporter-2 inhibitors treatment was associated with a reduction in left ventricular mass as assessed by cMRI.
No takes yet. Share an insight, caveat, or question.
Dhingra et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: